Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q1

8129.TEDINET S100RNXE
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥351.2bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥1.39T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥324.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥2.3bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥2.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥19.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥2.5bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥3.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥734.5bnat 2023-06-30Cons.Assets
Total assets¥715.3bnat 2023-03-31Cons.Assets
Total assets¥710.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥493.4bnat 2023-06-30Cons.Liabilities
Total liabilities¥472.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥241.1bnat 2023-06-30Cons.Net assets
Net assets / equity¥242.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥243.7bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥92.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥86.2bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥23.072023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥196.72022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.222022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥21.122023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥180.672022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio32.8%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥14.9bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥14.9bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥810m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2023-04-01 → 2023-06-30¥22.8bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2023-04-01 → 2023-06-30¥22.8bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2023-04-01 → 2023-06-30¥112m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2023-04-01 → 2023-06-30¥2.7bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2023-04-01 → 2023-06-30¥608m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥2.0bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2023-04-01 → 2023-06-30¥293m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2023-04-01 → 2023-06-30¥339.1bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2023-04-01 → 2023-06-30¥326.6bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥12.5bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.1bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥338m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥35m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥366.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥351.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥14.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥401m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥133m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-06-30¥612m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-06-30¥288m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-06-30¥312.7bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-06-30¥300.3bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥356m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥94m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥338.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥324.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥2.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 417
ItemContextValueUnit
Non controlling interestsPrior1YearInstant92000000JPY
Non controlling interestsCurrentQuarterInstant95000000JPY
Net assetsPrior1YearInstant242916000000JPY
Net assetsCurrentQuarterInstant241103000000JPY
Liabilities and net assetsPrior1YearInstant715288000000JPY
Liabilities and net assetsCurrentQuarterInstant734461000000JPY
Net salesPrior1YTDDuration324267000000JPY
Net salesCurrentYTDDuration351179000000JPY
Cost of salesPrior1YTDDuration297884000000JPY
Cost of salesCurrentYTDDuration324287000000JPY
Gross profitPrior1YTDDuration26383000000JPY
Gross profitCurrentYTDDuration26892000000JPY
Directors compensations salaries and allowances sgaPrior1YTDDuration10004000000JPY
Directors compensations salaries and allowances sgaCurrentYTDDuration9998000000JPY
Provision for bonuses sgaPrior1YTDDuration1712000000JPY
Provision for bonuses sgaCurrentYTDDuration1664000000JPY
Provision for directors bonuses sgaPrior1YTDDuration10000000JPY
Provision for directors bonuses sgaCurrentYTDDuration10000000JPY
Retirement benefit expenses sgaPrior1YTDDuration69000000JPY
Retirement benefit expenses sgaCurrentYTDDuration67000000JPY
Welfare expenses sgaPrior1YTDDuration1929000000JPY
Welfare expenses sgaCurrentYTDDuration1904000000JPY
Vehicle expenses sgaPrior1YTDDuration266000000JPY
Vehicle expenses sgaCurrentYTDDuration246000000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration-86000000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration54000000JPY
Depreciation sgaPrior1YTDDuration1360000000JPY
Depreciation sgaCurrentYTDDuration1467000000JPY
Amortization of goodwill sgaPrior1YTDDuration75000000JPY
Amortization of goodwill sgaCurrentYTDDuration67000000JPY
Rent expenses sgaPrior1YTDDuration1997000000JPY
Rent expenses sgaCurrentYTDDuration2124000000JPY
Taxes and dues sgaPrior1YTDDuration532000000JPY
Taxes and dues sgaCurrentYTDDuration546000000JPY
Exepences before deduction of temporary consumption tax payment sgaPrior1YTDDuration1619000000JPY
Exepences before deduction of temporary consumption tax payment sgaCurrentYTDDuration1682000000JPY
Other sgaPrior1YTDDuration4623000000JPY
Other sgaCurrentYTDDuration5203000000JPY
Selling general and administrative expensesPrior1YTDDuration24116000000JPY
Selling general and administrative expensesCurrentYTDDuration25038000000JPY
Operating incomePrior1YTDDuration2266000000JPY
Operating incomeCurrentYTDDuration1853000000JPY
Interest income noiPrior1YTDDuration13000000JPY
Interest income noiCurrentYTDDuration10000000JPY
Dividends income noiPrior1YTDDuration500000000JPY
Dividends income noiCurrentYTDDuration412000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration－JPY
Equity in earnings of affiliates noiCurrentYTDDuration91000000JPY
Real estate rent noiPrior1YTDDuration206000000JPY
Real estate rent noiCurrentYTDDuration209000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass